Nephros (NEPH) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Nephros (NEPH) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -83.04% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 112.62% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -51.05% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 56.15% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -73.02% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -31.93% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -7.28% |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 36.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.31% |
| Sep 30, 2025 | 36.52% |
| Jun 30, 2025 | 26.65% |
| Mar 31, 2025 | 26.73% |
| Dec 31, 2024 | 27.86% |
| Sep 30, 2024 | 37.98% |
| Jun 30, 2024 | 64.47% |
| Mar 31, 2024 | 57.38% |
| Dec 31, 2023 | 27.34% |
| Sep 30, 2023 | 79.76% |
| Jun 30, 2023 | 62.71% |
| Mar 31, 2023 | 35.10% |
| Dec 31, 2022 | -40.84% |
| Sep 30, 2022 | -11.40% |
| Jun 30, 2022 | -30.04% |
| Mar 31, 2022 | -12.71% |
| Dec 31, 2021 | -130.04% |
| Sep 30, 2021 | 15.42% |
| Jun 30, 2021 | -79.83% |
| Mar 31, 2021 | -81.68% |